相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Morbidity and mortality in PCOS: A prospective follow-up up to a mean age above 80 years
Maria Forslund et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)
To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study
Fatemeh Mahboobifard et al.
ADVANCES IN MEDICAL SCIENCES (2022)
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
Dorte Glintborg et al.
ENDOCRINE CONNECTIONS (2019)
Age and Gender Specific Thyroid Hormones and Their Relationships with Body Mass Index in a Large Chinese Population
Qianqian Song et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
PCOS and Hyperprolactinemia: what do we know in 2019?
Clemence Delcour et al.
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH (2019)
Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India
Mohammad Ashraf Ganie et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
The value of prolactin in predicting prolactinma in hyperprolactinaemic polycystic ovarian syndrome
Eleni Magdalini Kyritsi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
FERTILITY AND STERILITY (2018)
High androgen levels protect against hypothyroidism
Johanna Schmidt et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2017)
Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome
Maya Menon et al.
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2017)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Daria Lizneva et al.
FERTILITY AND STERILITY (2016)
Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome
H. N. Bui et al.
CLINICA CHIMICA ACTA (2015)
Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome
Sylvia A. Y. Hayashida et al.
CLINICAL ENDOCRINOLOGY (2014)
Serum Levels of Anti-histone and Anti-double-Strand DNA Antibodies Before and After Laparoscopic Ovarian Drilling in Women with Polycystic Ovarian Syndrome
Samsami Dehaghani Alamtaj et al.
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2014)
Prevalence of hyperprolactinaemia in female premenopausal blood donors
Macarena Alpanes et al.
CLINICAL ENDOCRINOLOGY (2013)
Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome
Maryam Kachuei et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Reproductive Hormone Levels and Anthropometry in Postmenopausal Women with Polycystic Ovary Syndrome (PCOS): A 21-Year Follow-Up Study of Women Diagnosed with PCOS around 50 Years Ago and Their Age-Matched Controls
Johanna Schmidt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Maternal hyperhomocysteinaemia is a risk factor for congenital heart disease
A. C. Verkleij-Hagoort et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome
OE Janssen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)